Should I buy Onto Innovation (ONTO) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 88% of its targets hit on this sector (8 calls tested). It aims for $410 (+40 %), call made on June 30, 2026, maturing on June 30, 2027 (59 d ago).
Firm-by-firm track record on Onto Innovation
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Benchmark | 80 % | +65.3 % | 15 | $160 -45% |
| B. Riley Securities | 80 % | +54.3 % | 15 | $330 +13% |
| Stifel | 80 % | +48.1 % | 10 | $350 +20% |
| Needham | 75 % | +44.6 % | 16 | $360 +23% |
| Oppenheimer | 43 % | +34.9 % | 7 | $450 +54% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
- Median price target $380, i.e. +30% from the current price ($293).
- The most reliable firm on ONTO, Cantor Fitzgerald (100% hit rate, 2 scored calls), targets $410 (call made on June 29, 2026, maturing on June 29, 2027) (+40%) in its most recent call, and $275 (call made on February 17, 2026, maturing on February 17, 2027) (-6%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on ONTO
Median target $380 (+30%) · 10 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Onto Innovation now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $380 (+30%), and Cantor Fitzgerald (most reliable on ONTO, 100%) targets $410. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Onto Innovation?
Not according to analysts: the median target ($380) is still +30% above the current price ($293) (most reliable on ONTO: Cantor Fitzgerald, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Onto Innovation still worth investing in?
It depends on the gap between the price ($293) and its estimated value: analysts target $380 on median (+30%), with 100% buys (most reliable on ONTO: Cantor Fitzgerald, 100%). Cross-check with their real reliability on ONTO and the cautions above. Information, not advice.
What's the main risk in buying ONTO?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Onto Innovation profile (consensus, analyst reliability, price target, performance).